Carysil Limited has formally announced the completion of Dr. Sonal Ambani's second term as Independent Director, effective March 31, 2026. The company disclosed this information to stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Term Completion Details

Dr. Sonal Ambani (DIN: 02404841) will cease to be an Independent Director of the company at the close of business hours on March 31, 2026. This marks the completion of her second and final consecutive term as an Independent Director, in accordance with the applicable provisions of the Companies Act, 2013 and SEBI Listing Regulations.

Committee Memberships

With the completion of her directorship, Dr. Ambani will also cease to be a member of multiple board committees. Her committee responsibilities included:

• Audit Committee – Member
• Nomination and Remuneration Committee – Member
• Stakeholders Relationship Committee – Member
• Corporate Social Responsibility Committee – Member
• Finance and Budget Committee – Member

Regulatory Compliance

The company has submitted the required disclosure under Regulation 30 read with Schedule III of the SEBI Listing Regulations. Carysil received a formal letter from Dr. Sonal Ambani regarding the completion of her term, confirming that her cessation is solely due to the completion of her second and final term as an Independent Director with no other material reasons.

Board Acknowledgment

The Board of Directors has placed on record its sincere appreciation and gratitude for Dr. Ambani's valuable guidance and contribution during her tenure as an Independent Director. In her communication to the company, Dr. Ambani expressed gratitude for the opportunity to serve as an Independent Director for two consecutive terms and thanked the Board for the support and cooperation extended during her tenure.

The company has requested the stock exchanges to treat this disclosure as compliance with the applicable provisions of the SEBI Listing Regulations and will complete all necessary formalities, including required filings and intimations with relevant regulatory authorities.

Carysil Limited has initiated the process to strike off its wholly owned subsidiary, Carysil Ceramictech Limited, through a voluntary closure application filed with the Registrar of Companies. The company disclosed this development in a regulatory filing dated March 31, 2026, submitted to both BSE Limited and the National Stock Exchange of India Limited under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Subsidiary Status and Operations

Carysil Ceramictech Limited has remained non-operational since its incorporation, with no business activities commenced to date. The subsidiary has made no financial contribution to the parent company during the last financial year.

Closure Process Timeline

The voluntary closure process is expected to be completed within 4-5 months, subject to receipt of regulatory approvals and completion of statutory formalities. This timeline indicates the company's structured approach to winding down the non-operational entity.

Regulatory Compliance

The filing follows the company's earlier intimation dated March 20, 2026, and complies with SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The disclosure includes comprehensive details as required under the regulatory framework.

Impact on Corporate Structure

Upon completion of the voluntary closure process, Carysil Ceramictech Limited will cease to be a subsidiary of Carysil Limited. Given the subsidiary's non-operational status and zero contribution to the parent company's financials, the striking off is not expected to have any material impact on Carysil Limited's business operations or financial performance.

The filing was signed by Reena Shah, Company Secretary & Compliance Officer, and includes detailed annexures addressing various regulatory requirements related to the subsidiary closure process.